Effect of PLGA NP size on efficiency to target traumatic brain injury

Journal of Controlled Release

Volumn 223, Issue , 2016, Pages 31-41

  Cruz, Luis J ^a   Stammes, Marieke A ^b   Que, Ivo ^a   Van Beek, Ermond R ^b   Knol Blankevoort, Vicky T ^a   Snoeks, Thomas J A ^a   Chan, Alan ^b   Kaijzel, Eric L ^a   Löwik, Clemens W G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PERCUROS B V   (Netherlands)

Author keywords

Brain injury; Contrast agents; Imaging; Nanoparticles; PLGA; Targeting

Indexed keywords

BRAIN; CELL DEATH; EFFICIENCY; IMAGING TECHNIQUES; MAMMALS; NANOPARTICLES; PATIENT TREATMENT; POLYETHYLENE GLYCOLS; POLYETHYLENES;

BRAIN INJURY; CONTRAST AGENT; INTRACELLULAR PROTEINS; PATHOLOGICAL CONDITIONS; PLGA; POLY(LACTIC-CO-GLYCOLIC ACID); TARGETING; TRAUMATIC BRAIN INJURIES;

DIAGNOSIS;

CELL PROTEIN; DICHLOROMETHANE; MACROGOL; N HYDROXYSUCCINIMIDE; NANOPARTICLE; POLYGLACTIN; BENZENESULFONIC ACID DERIVATIVE; DRUG CARRIER; FLUORESCENT DYE; INDOLE DERIVATIVE; IRDYE 800CW; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DESIGN; FEMALE; FLUORESCENCE IMAGING; IN VITRO STUDY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; PLASMA HALF LIFE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TRAUMATIC BRAIN INJURY; ANIMAL; BAGG ALBINO MOUSE; BRAIN; BRAIN INJURY; CHEMISTRY; METABOLISM; PARTICLE SIZE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; BENZENESULFONATES; BRAIN; BRAIN INJURIES; CELL LINE, TUMOR; DRUG CARRIERS; FEMALE; FLUORESCENT DYES; INDOLES; LACTIC ACID; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; TISSUE DISTRIBUTION;

EID: 84955087416     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.029     Document Type: Article

References (30)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, S. Dai, E.S. Ford, C.S. Fox, S. Franco, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, M.D. Huffman, S.E. Judd, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, R.H. Mackey, D.J. Magid, G.M. Marcus, A. Marelli, D.B. Matchar, D.K. McGuire, E.R. Mohler III, C.S. Moy, M.E. Mussolino, R.W. Neumar, G. Nichol, D.K. Pandey, N.P. Paynter, M.J. Reeves, P.D. Sorlie, J. Stein, A. Towfighi, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, M.B. Turner, and Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
2. S. Panagiotou, and S. Saha Therapeutic benefits of nanoparticles in stroke Front. Neurosci. 9 2015 182
3. P.L. Zhang, Y.X. Wang, Y. Chen, C.H. Zhang, C.H. Li, Z. Dong, H. Yin, F.F. Zhang, and J.H. Wang Use of intravenous thrombolytic therapy in acute ischemic stroke patients: evaluation of clinical outcomes Cell Biochem. Biophys. 2015
4. S.E. Lakhan, A. Kirchgessner, D. Tepper, and A. Leonard Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke Front. Neurol. 4 2013 32
5. C.M. Zehendner, L. Librizzi, M. de Curtis, C.R. Kuhlmann, and H.J. Luhmann Caspase-3 contributes to ZO-1 and Cl-5 tight-junction disruption in rapid anoxic neurovascular unit damage PLoS One 6 2011 e16760
6. S.C. Fagan, D.C. Hess, E.J. Hohnadel, D.M. Pollock, and A. Ergul Targets for vascular protection after acute ischemic stroke Stroke 35 2004 2220 2225
7. T. Ishii, T. Asai, T. Urakami, and N. Oku Accumulation of macromolecules in brain parenchyma in acute phase of cerebral infarction/reperfusion Brain Res. 1321 2010 164 168
8. T. Ishii, T. Fukuta, Y. Agato, D. Oyama, N. Yasuda, K. Shimizu, A.T. Kawaguchi, T. Asai, and N. Oku Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced Biochem. Biophys. Res. Commun. 430 2013 1201 1205
9. D.J. Mc Carthy, M. Malhotra, A.M. O'Mahony, J.F. Cryan, and C.M. O'Driscoll Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance Pharm. Res. 32 2015 1161 1185
10. S. Jain, D.G. Hirst, and J.M. O'Sullivan Gold nanoparticles as novel agents for cancer therapy Br. J. Radiol. 85 2012 101 113
11. R. Langer Drug delivery and targeting Nature 392 1998 5 10
12. B. Ruozi, D. Belletti, H.S. Sharma, A. Sharma, D.F. Muresanu, H. Mossler, F. Forni, M.A. Vandelli, and G. Tosi PLGA nanoparticles loaded cerebrolysin: studies on their preparation and investigation of the effect of storage and serum stability with reference to traumatic brain injury Mol. Neurobiol. 2015
13. E.A. Nance, G.F. Woodworth, K.A. Sailor, T.Y. Shih, Q. Xu, G. Swaminathan, D. Xiang, C. Eberhart, and J. Hanes A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue Sci. Transl. Med. 4 2012 (149ra119)
14. D. Bazile, C. Prud'homme, M.T. Bassoullet, M. Marlard, G. Spenlehauer, and M. Veillard Stealth me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system J. Pharm. Sci. 84 1995 493 498
15. L. Nobs, F. Buchegger, R. Gurny, and E. Allemann Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods Int. J. Pharm. 250 2003 327 337
16. F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov. Today 10 2005 1451 1458
17. L.J. Cruz, P.J. Tacken, R. Fokkink, B. Joosten, M.C. Stuart, F. Albericio, R. Torensma, and C.G. Figdor Targeted PLGA nano - but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro J. Control. Release 144 2010 118 126
18. L.J. Cruz, P.J. Tacken, F. Bonetto, S.I. Buschow, H.J. Croes, M. Wijers, I.J. de Vries, and C.G. Figdor Multimodal imaging of nanovaccine carriers targeted to human dendritic cells Mol. Pharm. 8 2011 520 531
19. L.J. Cruz, P.J. Tacken, I.S. Zeelenberg, M. Srinivas, F. Bonetto, B. Weigelin, C. Eich, I.J. de Vries, and C.G. Figdor Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organism Mol. Pharm. 11 2014 4299 4313
20. V.C. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref, D. Labarre, and G. Barratt Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules Biomaterials 22 2001 2967 2979
21. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
22. S. Sierra, M.C. Ramos, P. Molina, C. Esteo, J.A. Vazquez, and J.S. Burgos Statins as neuroprotectants: a comparative in vitro study of lipophilicity, blood-brain-barrier penetration, lowering of brain cholesterol, and decrease of neuron cell death J. Alzheimers Dis. 23 2011 307 318
23. B. Xie, M.A. Stammes, P.B. van Driel, L.J. Cruz, V.T. Knol-Blankevoort, M.A. Lowik, L. Mezzanotte, I. Que, A. Chan, J.P. van den Wijngaard, M. Siebes, S. Gottschalk, D. Razansky, V. Ntziachristos, S. Keereweer, R.W. Horobin, M. Hoehn, E.L. Kaijzel, E.R. van Beek, T.J. Snoeks, and C.W. Lowik Necrosis avid near infrared fluorescent cyanines for imaging cell death and their use to monitor therapeutic efficacy in mouse tumor models Oncotarget 2015
24. B.W. Pogue, K.D. Paulsen, S.M. Hull, K.S. Samkoe, J. Gunn, J. Hoopes, D.W. Roberts, T.V. Strong, D. Draney, and J. Feldwisch Advancing molecular - guided surgery through probe development and testing in a moderate cost evaluation pipeline Proc. SPIE Int. Soc. Opt. Eng. 9311 2015
25. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Ind. Pharm. 25 1999 471 476
26. L.J. Cruz, P.J. Tacken, R. Fokkink, B. Joosten, M.C. Stuart, F. Albericio, R. Torensma, and C.G. Figdor Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro J. Control. Release. 144 2010 118 126
27. C. Tassa, J.L. Duffner, T.A. Lewis, R. Weissleder, S.L. Schreiber, A.N. Koehler, and S.Y. Shaw Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles Bioconjug. Chem. 21 2010 14 19
28. C.F. Chignell Optical studies of drug-protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin Mol. Pharmacol. 6 1970 1 12
29. D.M. Togashi, and A.G. Ryder A fluorescence analysis of ANS bound to bovine serum albumin: binding properties revisited by using energy transfer J. Fluoresc. 18 2008 519 526
30. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Mol. Pharm. 5 2008 496 504